Magazine Store

10 Best Artificial Intelligence Companies to Watch 2020

Disrupt the clinical trial enrollment process by deploying AI-enabled patient-trial matching: Deep 6 AI


Up to 90% of all artificial intelligence (AI) algorithms created are never put into operation. Imagine just how much data could otherwise be used to create valuable insights. Deep 6 AI disrupts the clinical trial enrollment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, DEEP 6 AI finds more, better-matching patients for trials in minutes, not months. Deep 6 AI works with some of the most prominent health systems, pharma companies, and CROs in the world --making the DEEP 6 platform a crucial step in their clinical research workflow and greatly accelerating patients’ access to clinical trials. Deep 6 AI finds more patients for clinical trials in minutes rather than months, getting life-saving cures to people more quickly.

Deep 6 AI got its start by beating out some of the biggest names in analytics in a U.S. government-sponsored contest. This led to a contract with the U.S. intelligence community, which is perhaps the most complex data environment in the world. Since 2016, Deep 6 AI has focused exclusively on healthcare, participating in the Cedars-Sinai Accelerator Powered by Techstars, the Healthbox modified-accelerator program, and Stanford’s StartX Accelerator. Deep 6 AI was founded in 2015 and is based in Pasadena, CA. About 90% of all data in the world is unstructured, yet very few software tools know how to leverage the information it contains. Deep 6 AI builds applications that understand massive amounts of unstructured data at a very high speed and learn from users to single out the information that is most important to them. Deep 6 AI applies artificial intelligence and natural language processing to all clinical data to find eligible patients for clinical trials faster, accelerating recruitment exponentially and getting cures to the people who need them more quickly.


Deep 6 AI’s software analyzes structured data, such as ICD-10 codes, and unstructured clinical data, including doctor’s notes, pathology reports, operating notes and other important medical data in free-text form that cannot be searched easily. The software uses artificial intelligence and natural language processing to extract tens of thousands of new clinical data points – symptoms, diagnoses, treatments, genomics, lifestyle data, and more – turning fragmented medical documents into unified patient graphs that contain all the information needed to match complex clinical trial criteria. Deep 6 AI’s software also identifies patients with conditions not explicitly mentioned in medical records. As a result, Deep 6 AI’s software finds more patients who better match trial criteria in a fraction of the time.


  • Accelerate patient recruitment, getting life-saving cures to people faster
  • Identify patients who match complex trial criteria in minutes, not months
  • Bolster your reputation as a patient-centric leader in cutting-edge care
  • Complete trials faster so you can take on more trials, increasing revenue
  • Attract and retain better doctors
  • Lower labor costs related to patient medical record research and evaluation
  • Refer patients to trials when the standard of care falls short
  • Improve patient outcomes and satisfaction scores
  • Give patients access to cutting-edge drugs and therapies with a single click


Software developed by Deep 6 AI, an AI-based trials recruitment company in Pasadena, California, was used by researchers at Cedars-Sinai Smidt Heart Institute in Los Angeles, California, to find 16 suitable participants for a trial in one hour. A conventional approach had turned up only two people in six months.

WHO the Deep 6 AI HELPS


  • Complete clinical trials faster and take on more research, increasing revenues
  • Improve patient outcomes and satisfaction
  • Attract and retain better physicians and researchers


Refer patients to trials when the standard of care falls short


  • Get access to cutting-edge therapies with a single click
  • Take more control over health and treatment options


  • Select clinical trial sites based on real-time patient data
  • Accelerate patient recruitment for faster time to market and more time under patent
  • Get real-time study results

WOUT BRUSSELAERS CEO and Co-founder of Deep 6 AI

Wout started his career as a diplomat in the Middle East before joining a global management consulting firm, McKinsey & Company, serving a wide variety of industries across Asia. Next, Wout founded an extreme sports adventure company in Singapore and then spent five years in the high-stakes world of international security, growing and leading a 22,000-headcount organization across four continents into a $500M global player. In 2015, Wout co-founded Deep 6 AI. Wout is a frequent speaker on artificial intelligence in healthcare and works closely with hospitals, pharma companies and research institutes on patient recruitment programs.

ERIC GILDENHUYS Vice President of Deep 6 AI

Eric is responsible for developing and executing on the sales strategy for Life Sciences, Pharma, CROs, and Partnerships for Deep 6 AI. Eric has 25 years’ experience helping companies improve their revenue streams. He began his career by co-founding and selling a software company to Optio Software, helping guide Optio to a successful IPO by expanding into the healthcare market and launching its European headquarters. For the last 14 years, Eric has been helping software and professional services firms such as PwC all over the world in shifting the paradigm of their business development culture, resulting in new contracts worth $100+ million.

“Deep 6 AI® finds more, better-qualified patients for clinical trials in minutes rather than months. Using artificial intelligence on medical records, we accelerate patient recruitment exponentially, getting life-saving cures to people faster.”